Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -33.26 | N/A |
| PEG Ratio (TTM) | 0.14 | N/A |
| P/S Ratio (TTM) | -23.72 | N/A |
| P/B Ratio (TTM) | 0.98 | N/A |
| P/FCF Ratio (TTM) | 0.00 | N/A |
| Price to 5YR AVG Earnings Ratio | -82.43 | N/A |
| Price to 5YR AVG FCF Ratio | 7.03 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.50% | N/A |
| ROE (TTM) | -3.09% | N/A |
| Net Profit Margin (TTM) | 68.07% | N/A |
| ROIC 5YR AVG | 4.25% | N/A |
Growth (92%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 37.90% | 684.67% | 364.80% |
| Revenue | -196.00% | 130.34% | 49.65% |
| Net Income | 36.84% | 687.46% | 366.53% |
| Cash Flow | 130,212,268.19% | 42.27% | 55.39% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 775,789.27 | N/A |
| Quick Ratio (TTM) | 775,789.27 | N/A |
| D/E Ratio (TTM) | 0.17 | N/A |
| Interest Coverage (TTM) | 0.42 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 1.74% | N/A |